Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-009982
Filing Date
2026-03-13
Accepted
2026-03-13 08:00:01
Documents
1
Period of Report
2026-03-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3130
  Complete submission text file 0001493152-26-009982.txt   4543
Mailing Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada
Business Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada 4036707377
ONCOLYTICS BIOTECH INC (Issuer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4350 EXECUTIVE DRIVE, SUITE 325 SAN DIEGO CA 92121
Business Address
Kelly Jared (Reporting) CIK: 0002103581 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38512 | Film No.: 26750104